This report contains market size and forecasts of PD-L1 Biomarker Testing in Global, including the following market information:
Global PD-L1 Biomarker Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global PD-L1 Biomarker Testing market was valued at 1052.2 million in 2020 and is projected to reach US$ 3710.5 million by 2027, at a CAGR of 37.0% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-L1 Biomarker Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-L1 Biomarker Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global PD-L1 Biomarker Testing Market Segment Percentages, By Type, 2020 (%)
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
China PD-L1 Biomarker Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China PD-L1 Biomarker Testing Market Segment Percentages, By Application, 2020 (%)
Hospital
Diagnostic Center
Others
Global PD-L1 Biomarker Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global PD-L1 Biomarker Testing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total PD-L1 Biomarker Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total PD-L1 Biomarker Testing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 PD-L1 Biomarker Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PD-L1 Biomarker Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PD-L1 Biomarker Testing Overall Market Size
2.1 Global PD-L1 Biomarker Testing Market Size: 2021 VS 2027
2.2 Global PD-L1 Biomarker Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top PD-L1 Biomarker Testing Players in Global Market
3.2 Top Global PD-L1 Biomarker Testing Companies Ranked by Revenue
3.3 Global PD-L1 Biomarker Testing Revenue by Companies
3.4 Top 3 and Top 5 PD-L1 Biomarker Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies PD-L1 Biomarker Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 PD-L1 Biomarker Testing Players in Global Market
3.6.1 List of Global Tier 1 PD-L1 Biomarker Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 PD-L1 Biomarker Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global PD-L1 Biomarker Testing Market Size Markets, 2021 & 2027
4.1.2 PD-L1 (22C3)
4.1.3 PD-L1(28-8)
4.1.4 PD-L1 (SP142)
4.1.5 PD-L1 (SP263)
4.1.6 Other
4.2 By Type - Global PD-L1 Biomarker Testing Revenue & Forecasts
4.2.1 By Type - Global PD-L1 Biomarker Testing Revenue, 2016-2021
4.2.2 By Type - Global PD-L1 Biomarker Testing Revenue, 2022-2027
4.2.3 By Type - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PD-L1 Biomarker Testing Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Others
5.2 By Application - Global PD-L1 Biomarker Testing Revenue & Forecasts
5.2.1 By Application - Global PD-L1 Biomarker Testing Revenue, 2016-2021
5.2.2 By Application - Global PD-L1 Biomarker Testing Revenue, 2022-2027
5.2.3 By Application - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global PD-L1 Biomarker Testing Market Size, 2021 & 2027
6.2 By Region - Global PD-L1 Biomarker Testing Revenue & Forecasts
6.2.1 By Region - Global PD-L1 Biomarker Testing Revenue, 2016-2021
6.2.2 By Region - Global PD-L1 Biomarker Testing Revenue, 2022-2027
6.2.3 By Region - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America PD-L1 Biomarker Testing Revenue, 2016-2027
6.3.2 US PD-L1 Biomarker Testing Market Size, 2016-2027
6.3.3 Canada PD-L1 Biomarker Testing Market Size, 2016-2027
6.3.4 Mexico PD-L1 Biomarker Testing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe PD-L1 Biomarker Testing Revenue, 2016-2027
6.4.2 Germany PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.3 France PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.4 U.K. PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.5 Italy PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.6 Russia PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.7 Nordic Countries PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.8 Benelux PD-L1 Biomarker Testing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia PD-L1 Biomarker Testing Revenue, 2016-2027
6.5.2 China PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.3 Japan PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.4 South Korea PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.5 Southeast Asia PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.6 India PD-L1 Biomarker Testing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America PD-L1 Biomarker Testing Revenue, 2016-2027
6.6.2 Brazil PD-L1 Biomarker Testing Market Size, 2016-2027
6.6.3 Argentina PD-L1 Biomarker Testing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa PD-L1 Biomarker Testing Revenue, 2016-2027
6.7.2 Turkey PD-L1 Biomarker Testing Market Size, 2016-2027
6.7.3 Israel PD-L1 Biomarker Testing Market Size, 2016-2027
6.7.4 Saudi Arabia PD-L1 Biomarker Testing Market Size, 2016-2027
6.7.5 UAE PD-L1 Biomarker Testing Market Size, 2016-2027
7 Players Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Corporate Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies PD-L1 Biomarker Testing Major Product Offerings
7.1.4 Agilent Technologies PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.1.5 Agilent Technologies Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche PD-L1 Biomarker Testing Major Product Offerings
7.2.4 Roche PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck PD-L1 Biomarker Testing Major Product Offerings
7.3.4 Merck PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Major Product Offerings
7.4.4 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca PD-L1 Biomarker Testing Major Product Offerings
7.5.4 AstraZeneca PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.5.5 AstraZeneca Key News
7.6 Ono Pharmaceutical
7.6.1 Ono Pharmaceutical Corporate Summary
7.6.2 Ono Pharmaceutical Business Overview
7.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Major Product Offerings
7.6.4 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.6.5 Ono Pharmaceutical Key News
7.7 Regeneron
7.7.1 Regeneron Corporate Summary
7.7.2 Regeneron Business Overview
7.7.3 Regeneron PD-L1 Biomarker Testing Major Product Offerings
7.4.4 Regeneron PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.7.5 Regeneron Key News
7.8 Innovent
7.8.1 Innovent Corporate Summary
7.8.2 Innovent Business Overview
7.8.3 Innovent PD-L1 Biomarker Testing Major Product Offerings
7.8.4 Innovent PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.8.5 Innovent Key News
7.9 Hengrui Medicine
7.9.1 Hengrui Medicine Corporate Summary
7.9.2 Hengrui Medicine Business Overview
7.9.3 Hengrui Medicine PD-L1 Biomarker Testing Major Product Offerings
7.9.4 Hengrui Medicine PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.9.5 Hengrui Medicine Key News
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Corporate Summary
7.10.2 Junshi Biosciences Business Overview
7.10.3 Junshi Biosciences PD-L1 Biomarker Testing Major Product Offerings
7.10.4 Junshi Biosciences PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.10.5 Junshi Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. PD-L1 Biomarker Testing Market Opportunities & Trends in Global Market
Table 2. PD-L1 Biomarker Testing Market Drivers in Global Market
Table 3. PD-L1 Biomarker Testing Market Restraints in Global Market
Table 4. Key Players of PD-L1 Biomarker Testing in Global Market
Table 5. Top PD-L1 Biomarker Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global PD-L1 Biomarker Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global PD-L1 Biomarker Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies PD-L1 Biomarker Testing Product Type
Table 9. List of Global Tier 1 PD-L1 Biomarker Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PD-L1 Biomarker Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences